| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |